The present invention relates to administration methods and dosage regimens for treatment of neurodegenerative diseases, in particular ALS, using trametinib. The administration methods and dosage regimens induce neural regeneration and changes in gene expression.
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING TRAMETINIB